ACIP Upheaval Leaves Merck & Co. In A Lurch

 
• By Jessica Merrill and Bridget Silverman
  
Merck's CEO still expects the June ACIP meeting to take place as scheduled despite all of the committee members being removed. (Shutterstock)

More from Vaccines

More from Agency Leadership